Skip to main content
Equibles
OTLK logo

OTLK · Outlook Therapeutics, Inc. · Supply Chain

Track OTLK — free

Use OTLK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OTLK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.56 +0.04 (+7.94%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Because our cash and cash equivalents, together with $51.1 million of net proceeds from our August 2026 Offering, will not be adequate to fund our currently planned operations through at least the 12 months from the date of this Quarterly Report, there is substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 18, 2026
Market Cap
$126.59M
Shares
243.45M
Volume · Oct 21 3M Avg daily vol (3M) 12.61M

Supply Chain

Customers, suppliers, competitors and partners named in annual 10-K reports: OTLK's own, and those of other companies that name OTLK.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who OTLK sells to, buys from and competes with

  • 0 suppliers
  • 0 customers
  • 1 competitor

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1649989 CUSIP 69012T305 13F (30d) 19 filings 8 filers Visit website Investor relations